Skip to main content
. 2016 Jan 13;6(1):e010210. doi: 10.1136/bmjopen-2015-010210

FigureĀ 1.

FigureĀ 1

Prevalence of prescribing of different anti-diabetic medications among all patients with type 2 diabetes on treatment. *Other=Sum of prevalence of Acarbose, GLP-1 analogues, Meglitinides and SGLT-2 inhibitors. **For detailed values of point estimates and CIs, please consult online supplementary appendix 3.